Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
109.52
+12.99 (13.46%)
May 4, 2026, 12:07 PM EDT - Market open
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.68 billion as of May 4, 2026. Its market cap has increased by 248.49% in one year.
Market Cap
6.68B
Enterprise Value
6.57B
1-Year Change
248.49%
Ranking
Category
Stock Price
$109.52
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.68B, an increase of 2,146.87%. That is a compound annual growth rate of 58.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 5.89B | 44.18% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 6.26B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.11B |
| Belite Bio | 6.09B |
| Celcuity | 6.07B |
| Spyre Therapeutics | 5.99B |
| Apogee Therapeutics | 5.96B |
| CG Oncology | 5.60B |